Read + Share
Amedeo Smart
Independent Medical Education
Oaknin A, Monk BJ, de Melo AC, Kim HS, et al. Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial. Eur J Cancer 2025;216:115146.PMID: 39798514
Email
LinkedIn
Privacy Policy